Flunitrazolam

Flunitrazolam (FNTZ, Flunazolam) is a triazolobenzodiazepine (TBZD), which are benzodiazepine (BZD) derivatives, that has been sold online as a designer drug, and is a potent hypnotic and sedative drug similar to related compounds such as flunitrazepam, clonazolam and flubromazolam. It was first definitively identified and reported to the EMCDDA Early Warning System, by an analytical laboratory in Germany in October 2016,^[2] and had not been described in the scientific or patent literature before this.^[3] It is the triazole analogue of Flunitrazepam (Rohypnol). The addition of the triazole ring to the scaffold increases potency significantly, this is evident as flunitrazolam is reported anecdotally to be active in the microgram level.^[4][5] It is active at 0.1 mg.

Legal status

• BR: Class B1 (Psychoactive drugs)^[1]
• CA: Schedule IV
• DE: NpSG (Industrial and scientific use only)
• UK: Under Psychoactive Substances Act

CAS Number

• 2243815-18-9 ^Y

PubChem CID

• 137700379

ChemSpider

• 59718543

Quick facts Legal status, Identifiers ...

Flunitrazolam

Legal status
Legal status	BR: Class B1 (Psychoactive drugs)[1] CA: Schedule IV DE: NpSG (Industrial and scientific use only) UK: Under Psychoactive Substances Act
Identifiers
IUPAC name 1-methyl-8-nitro-6-(2-fluorophenyl)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
CAS Number	2243815-18-9 Y
PubChem CID	137700379
ChemSpider	59718543
UNII	OK0I6HTR1Y
CompTox Dashboard (EPA)	DTXSID601024059
ECHA InfoCard	100.439.381
Chemical and physical data
Formula	C17H12FN5O2
Molar mass	337.314 g·mol−1
3D model (JSmol)	Interactive image
SMILES O=[N](=O)c4ccc2-n1c(C)nnc1CN=C(c2c4)c3ccccc3F
InChI InChI=1S/C17H12FN5O2/c1-10-20-21-16-9-19-17(12-4-2-3-5-14(12)18)13-8-11(23(24)25)6-7-15(13)22(10)16/h2-8H,9H2,1H3 Key:RDLAGIOILLWVTM-UHFFFAOYSA-N

Close